KPTI icon

Karyopharm Therapeutics
KPTI

Overview Fund Activity

157 hedge funds and large institutions have $949M invested in Karyopharm Therapeutics in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
+2
Holders Change %
+1.29%
% of All Funds
3.18%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
29
Increased
55
Reduced
53
Closed
27
Calls
$7.81M
Puts
$4.85M
Net Calls
+$2.96M
Net Calls Change
-$5.5M

Top Buyers

1
Two Sigma Investments
Two Sigma Investments
New York
+$15.4M
2
FCM
Frontier Capital Management
Massachusetts
+$13.3M
3
PAI
Palo Alto Investors
California
+$12.7M
4
Citadel Advisors
Citadel Advisors
Florida
+$11.5M
5
BlackRock
BlackRock
New York
+$11.4M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$123M
2
FCM
Farallon Capital Management
California
-$25.3M
3
Goldman Sachs
Goldman Sachs
New York
-$16.6M
4
ACA
Avoro Capital Advisors
New York
-$14.6M
5
WP
Woodline Partners
California
-$8.77M
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
176
SG3 Management
Puerto Rico
– -$95K -333 Closed
WAM
177
Wolverine Asset Management
Illinois
– -$40K -142 Closed
CAN
178
Cetera Advisor Networks
California
– -$30K -107 Closed
BFIM
179
Beese Fulmer Investment Management
Ohio
– -$12K -43 Closed
PAG
180
Private Advisor Group
New Jersey
– -$7K -23 Closed
TFS
181
TrustCore Financial Services
Tennessee
– -$6K -20 Closed
APA
182
American Portfolios Advisors
New York
– -$5.68K -20 Closed
MAM
183
Meeder Asset Management
Ohio
– -$3K -11 Closed
TI
184
tru Independence
Oregon
– -$3 -10 Closed
4 5 6 7
8